170 related articles for article (PubMed ID: 3149632)
1. Comparison of bactericidal activity of selected beta-lactam antimicrobials against Pseudomonas aeruginosa.
Smith JA; Henry DA
J Antimicrob Chemother; 1988 Dec; 22(6):849-55. PubMed ID: 3149632
[TBL] [Abstract][Full Text] [Related]
2.
Goodlet KJ; Nicolau DP; Nailor MD
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
[TBL] [Abstract][Full Text] [Related]
3. Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
Fernandes CJ; Stevens DA; Ackerman VP
Chemotherapy; 1985; 31(4):292-6. PubMed ID: 3928282
[TBL] [Abstract][Full Text] [Related]
4. The activity of ceftazidime, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
Rolston KV; Chandrasekar PH; LeFrock JL; Schell RF
Chemotherapy; 1984; 30(1):31-4. PubMed ID: 6420119
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies of investigational beta-lactams as possible therapy for Pseudomonas aeruginosa endocarditis.
Zar FA; Kany RJ
Antimicrob Agents Chemother; 1985 Jan; 27(1):1-3. PubMed ID: 3920956
[TBL] [Abstract][Full Text] [Related]
6. In-vitro susceptibility of Pseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides.
Van der Auwera P; Schuyteneer F
J Antimicrob Chemother; 1983 Jun; 11(6):511-5. PubMed ID: 6411673
[TBL] [Abstract][Full Text] [Related]
7. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Scribner RK; Marks MI; Weber AH; Tarpay MM; Welch DF
Antimicrob Agents Chemother; 1982 Jun; 21(6):939-43. PubMed ID: 6810757
[TBL] [Abstract][Full Text] [Related]
8. In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.
Owens RC; Banevicius MA; Nicolau DP; Nightingale CH; Quintiliani R
Antimicrob Agents Chemother; 1997 Nov; 41(11):2586-8. PubMed ID: 9371376
[TBL] [Abstract][Full Text] [Related]
9. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa.
Cappelletty DM; Rybak MJ
Antimicrob Agents Chemother; 1996 Mar; 40(3):677-83. PubMed ID: 8851592
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.
Li C; Nicolau DP; Lister PD; Quintiliani R; Nightingale CH
J Antimicrob Chemother; 2004 Feb; 53(2):297-304. PubMed ID: 14729755
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
Lyon MD; Smith KR; Saag MS; Cloud GA; Cobbs CG
Antimicrob Agents Chemother; 1986 Jul; 30(1):25-30. PubMed ID: 3092731
[TBL] [Abstract][Full Text] [Related]
12. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Petit JC; Richard G; Burghoffer B; Daguet GL
Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
[TBL] [Abstract][Full Text] [Related]
13. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
[TBL] [Abstract][Full Text] [Related]
14. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
Hoogkamp-Korstanje JA; Westerdaal NA
Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
[TBL] [Abstract][Full Text] [Related]
15. Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
Lerner SA; Dudek EJ; Boisvert WE; Berndt KD
Rev Infect Dis; 1984; 6 Suppl 3():S678-88. PubMed ID: 6443769
[TBL] [Abstract][Full Text] [Related]
16. Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).
Jones RN; Stilwell MG; Rhomberg PR; Sader HS
Diagn Microbiol Infect Dis; 2009 Nov; 65(3):331-4. PubMed ID: 19822273
[TBL] [Abstract][Full Text] [Related]
17. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
[TBL] [Abstract][Full Text] [Related]
18. Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by Pseudomonas aeruginosa.
Weiss K; Lapointe JR
Antimicrob Agents Chemother; 1995 Nov; 39(11):2411-4. PubMed ID: 8585718
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
[TBL] [Abstract][Full Text] [Related]
20. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
Henderson A; Tan E; McCarthy KL; Paterson DL
Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]